The Cooper Companies, Inc
- Industria
- Medical Devices
- Bolsa
- EE. UU.
- País / Región
- USA
- Fecha de salida a bolsa
- 30 de diciembre de 1983
- Empleados
- 15.000
- Sitio web
- www.coopercos.com
Rango de valoración compuesto · conservador $42–$50 / razonable $50–$60 / optimista $60–$70. A $65.91, Dentro del rango de valor intrínseco optimista · con muchas expectativas ya descontadas.
Al publicar $62.55 (24 de mayo de 2026)
Aún no hay análisis sobre este valor en tu idioma.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.
Historia
PróximamenteEsta sección se está completando; vuelve pronto.
Posición en el sector
PróximamenteEsta sección se está completando; vuelve pronto.
